View Full Version : Lupus Research Institute Highly Encouraged By FDA Advisory Committee's Recommendation

11-17-2010, 09:10 AM
The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations are pleased with the U.S. Food and Drug Administration (FDA) Advisory Committee's vote to recommend approval of BenlystaŽ for active systemic lupus erythematosus (SLE), offering patients new found hope for the first approved treatment option in more than 50 years. The U.S...

More... (http://mnt.to/f/3MJv)